Abstract-Obesity is associated with a higher risk of developing diabetes mellitus (DM), hypertension (HT), and left ventricular hypertrophy (LVH). The present study assessed in the general population the impact of body weight and visceral obesity on the development of alterations in glucose metabolism and cardiac structure, as well as of elevation in blood pressure. In 1412 subjects randomly selected and representative of the general population of Monza, we assessed twice (in 1990/1991 and 2000/2001) body mass index (BMI); waist circumference; office, home, and 24-hour ambulatory (24-hour) blood pressure, fasting glycemia, and left ventricular mass (echocardiography). New-onset high-risk conditions were DM; impaired fasting glucose; office, home, and 24-hour HT; and LVH. O besity has been shown to be associated with a higher risk of cardiovascular morbidity and mortality. 1-5 Evidence has also been obtained that the risk of developing diabetes mellitus (DM) is much greater in obese than in lean individuals and that this is the case also for the risk of developing high blood pressure (BP). 6 -8 This has made loss of body weight, as well as body weight maintenance (rather than an increase), with age a consistent recommendation of all guidelines on cardiovascular treatment and prevention. 9 -12 In the Pressioni Arteriose Monitorate e Loro Associazioni Study, a northern Italian population was examined twice at a 10-year interval, with data collection including body mass index (BMI); waist circumference (WC); blood glucose; office, home, and ambulatory BP; and echocardiographic left ventricular mass index (LVMI). This allowed us to determine the long-term risk of developing alterations in glucose metabolism; office, home, and ambulatory hypertension (HT); and left ventricular hypertrophy (LVH) associated with a wide range of body weight values and to compare the predictive ability for the above conditions related to peripheral or visceral obesity. To our knowledge, such a comprehensive assessment of the long-term risk of new-onset DM, in-office and out-of-office HT, and cardiac organ damage associated with obesity has never been obtained before at a population level.
O besity has been shown to be associated with a higher risk of cardiovascular morbidity and mortality. [1] [2] [3] [4] [5] Evidence has also been obtained that the risk of developing diabetes mellitus (DM) is much greater in obese than in lean individuals and that this is the case also for the risk of developing high blood pressure (BP). 6 -8 This has made loss of body weight, as well as body weight maintenance (rather than an increase), with age a consistent recommendation of all guidelines on cardiovascular treatment and prevention. 9 -12 In the Pressioni Arteriose Monitorate e Loro Associazioni Study, a northern Italian population was examined twice at a 10-year interval, with data collection including body mass index (BMI); waist circumference (WC); blood glucose; office, home, and ambulatory BP; and echocardiographic left ventricular mass index (LVMI). This allowed us to determine the long-term risk of developing alterations in glucose metabolism; office, home, and ambulatory hypertension (HT); and left ventricular hypertrophy (LVH) associated with a wide range of body weight values and to compare the predictive ability for the above conditions related to peripheral or visceral obesity. To our knowledge, such a comprehensive assessment of the long-term risk of new-onset DM, in-office and out-of-office HT, and cardiac organ damage associated with obesity has never been obtained before at a population level.
Methods
The methodology of the Pressioni Arteriose Monitorate e Loro Associazioni Study has been reported in detail previously. 13, 14 Briefly, 3200 individuals (all white) were randomly selected from the residents in Monza (a town in the northeast outskirts of Milan) to be representative of the general population for sex, decades of age (25-74 years) , and socioeconomic conditions, according to the criteria used in the World Health Organization Monitoring Disease project performed in the same geographic area. 15 From 1990 to 1993, participants were invited to the outpatient clinic of the local hospital (San Gerardo) in the morning of a working day (Monday through Friday) where several data were collected. Those relevant to the present study are as follows: (1) body weight, height, WC (measurements at the midpoint between the lower ribs and the iliac crest with the subject in the standing position), and BMI, calculated as weight in kilograms divided by the square of the height in meters; (2) 3 office BP values, obtained by a sphygmomanometer with the subject in the sitting position, together with heart rate measurement by the palpatory method; (3) a 24-hour ambulatory BP monitoring by an oscillometric device (SpaceLabs 90207, SpaceLabs) with the BP readings set at 20-minute intervals; (4) 2 home BP measurements (7:00 AM and 7:00 PM) by a semiautomatic device (model HP 5331, Philips), using the arm contralateral to that used for ambulatory monitoring; (5) blood glucose (standard glucose oxydase method) from a venous sample collected in the morning after an overnight fasting; (6) echocardiographic left ventricular wall and diameter values, which were used to calculate left ventricular mass and indexed for body surface area (LVMI) 16 ; and (7) information on other cardiovascular risk factors, previous cardiovascular events, and drug therapy, derived from history and physical examination. The overall participation rate was 64%, consistent for all of the age and sex subgroups. The demographic characteristics of nonparticipants were similar to those of participants. This was the case also for the clinical characteristics (history of cardiovascular events, smoking habits, current and previous BP values, use of cardiovascular and metabolic drugs, etc), as assessed by telephone interviews.
Participants were contacted 10 years later (from 2001 to 2003), and survivors willing to be re-examined were asked to come to the San Gerardo Hospital again to collect the same set of data, according to the same measuring procedures. New-onset DM was diagnosed if subjects who were nondiabetic at the first examination showed at the second examination a fasting plasma glucose Ն126 mg/dL or reported use of antidiabetic drugs. A new-onset impaired fasting glucose (IFG) condition was diagnosed if subjects with a plasma glucose value Ͻ110 mg/dL at the first examination showed a value Ն110 at the second one. New-onset office, home, or ambulatory HT was diagnosed if normotensive subjects at the first examination reported at the second examination use of antihypertensive drugs or showed an office BP Ն140 mm Hg systolic or Ն90 mm Hg diastolic, a home BP Ն132 mm Hg systolic or Ն83 mm Hg diastolic, or a 24-hour mean BP Ն125 mm Hg systolic or Ն79 mm Hg diastolic. These BP values (which were defined from previous analyses of the Pressioni Arteriose Monitorate e Loro Associazioni data) 14, 17 are similar to those mentioned by guidelines on HT as dividing in-office and out-of-office normotension from HT. 10, 11 New-onset LVH was diagnosed if, at the second examination, LVMI had increased to a value Ն111 g/m 2 in men and Ն106 g/m 2 in women. 18 In each individual, office, home, and 24-hour BP values were averaged separately for the 2 sets of data collection after exclusion of artifactual ambulatory BP readings based on preselected criteria. 14, 17, 19 Data were expressed as meanϮSD for quintiles of BMI or WC, using different values for men and women. Comparisons among quintiles were done by ANOVA (mean values) or 2 test (prevalence). P values for trend across quintiles were calculated by regression model or by Cochran-Armitage trend test after adjusting for age and sex. A modified Poisson approach, using robust error variance, 20 was used to estimate for each BMI or WC quintile the relative risk of developing an IFG condition; DM; office, home, and ambulatory HT; and LVH, taking the quintile with the lowest baseline BMI or WC values as reference. Relative risk calculations were also made after adjustment for potentially confounding factors, that is, age; sex; antihypertensive therapy; baseline blood glucose (for new-onset IFG or DM); baseline office, home, and 24-hour systolic BP (for new-onset office, home, and ambulatory HT, respectively); and baseline LVMI and 24-hour systolic BP and BP difference between the 2 examinations (for new-onset LVH), based on the superior relationship that ambulatory BP has with left ventricular mass values. 21, 22 The above factors were also included in a multivariate analysis to determine their independent contribution, as well as relative impact. Finally, calculation was also made of the adjusted relative risk of developing all of the above conditions: (1) for a unit increment of BMI (1 kg/m 2 ) or WC (1 cm); (2) for the 10-year absolute BMI and WC changes; and (3) for the receiveroperating characteristic curves (ROC) predicting all of the above new-onset conditions for baseline BMI and WC, baseline BMI plus WC, and baseline BMI plus WC values plus the BMI or WC absolute changes. The areas under the respective curve (AUC) were compared by Mann-Whitney statistics. When investigating the predictive value of BMI or WC changes, adjustments included baseline BMI or WC. A P value Ͻ0.05 was considered statistically significant. All of the statistical analyses were conducted using SAS statistical software version 9.1 (SAS Institute, Cary, NC).
Results

Baselines Values
A total of 157 subjects examined between 1990 and 1993 died over the following 10 years, whereas 482 subjects (23.5%) did not come to the second examination, for a variety of reasons, that is, incompatibility with the working schedule, change in residence, refusal, and so forth. The mean age (first examination) of the subjects who did not come to the second examination was always higher (53.9Ϯ14.5 years) than that of the subjects who were examined a second time (please see Table and Table S1 , available in the online Data Supplement at http://hyper.ahajournals.org), whereas the male prevalence was lower (42.5%). The Table shows that, in the 1412 subjects in which data were collected a second time, at the first examination, mean age, cardiovascular event history, blood glucose, in-office and out-of-office BP, and LVMI all showed a significant progressive increase from the quintile with the lowest to the quintile with highest BMI. This was the case also for WC quintiles (please see Table S1 ).
Baseline BMI or WC and New-Onset DM or an IFG Condition
Between the first and the second examination, there were 53 and 101 cases of new-onset DM and of an IFG condition, respectively. As shown in Figure 1 , top left, the incidence of DM increased significantly and progressively from the quintile with the lowest to the quintile with the highest BMI or WC. This was the case also for the unadjusted risk of developing these conditions (please see Figure S1 ) The adjusted risk of the quintile with the greatest BMI or WC value was, respectively, Ͼ3.2 and 4.4 times than that of the quintile with the lowest BMI or WC (Figure 1 , central and right panels). Similar findings were obtained for the incidence and risk of new-onset IFG condition ( Figure 1 , bottom panels). The adjusted risk of developing DM increased by 8.4% and 3.2%, respectively, for an increase of BMI of 1 kg/m 2 and of WC of 1 cm. The corresponding increase of the risk of developing an IFG was 9.5% and 3.5% (please see Table S2 ). In multivariate analysis (see Methods), BMI or WC was independently predictive of new-onset DM or IFG condition, its impact after blood glucose, and preceding sex (female versus male) and antihypertensive drug treatment (please see Table S3 ).
Baseline BMI or WC and New-Onset In-and Out-of-Office HT
Over the 10-year period between collection of the 2 data sets there were 341, 247, and 355 cases of new-onset office, home, and ambulatory HT, respectively. As shown in Figure  2 (left), the incidence of all of the new-onset HTs increased progressively and steeply from the quintile with the lowest to the quintile with the greatest BMI or WC values, the trend being in each instance statistically significant. The unadjusted risk of each condition also increased progressively from the lowest to the highest quintile of BMI or WC (please see Figure S1 ). For the quintile with the greatest BMI or WC values, the adjusted risk of developing in-or out-of-office HT was between 1.5 and 2.0 times that of the quintile with the lowest BMI or WC values ( Figure 2 , central and right panels). The risk of developing office, home, and ambulatory HT increased by 4.2%, 3.9%, and 2.5%, respectively, for an increase of BMI of 1 kg/m 2 . The corresponding figures for an increase of WC of 1 cm were 1.8%, 1.5%, and 1.4%, respectively (please see Table S2 ). In the multivariate analysis (see Methods), BMI or WC was always independently predictive of in-or out-of-office HT, its impact usually after systolic BP and age (please see Table S3 ).
Baseline BMI or WC and New-Onset LVH
Over the 10 years between collection of the 2 sets of data there were 230 new cases of LVH. As shown in Figure 3 , left, the incidence of new-onset LVH increased progressively and steeply from the quintile with the lowest to the quintile with the highest BMI or WC value, again with a significant P value for trend. This was the case also for the unadjusted risk of developing LVH (please see Figure S1 ). For the quintile with the highest BMI or WC value, the adjusted risk of developing LVH was more than twice that of the quintile with the lowest BMI or WC value ( Figure 3 , central and right panels). The risk of developing LVH increased by 5.1% and 2.6% for an increase in BMI of 1 kg/m 2 and of WC of 1 cm, respectively (please see Table S2 ). In the multivariate analysis (see Methods), BMI or WC was independently predictive of new-onset LVH, its impact after LVMI, and age (please see Table S3 ).
Baseline BMI or WC Values and 10-Year Absolute Changes in Blood Glucose, BP, and LVMI
Over the 10 years between the first and the second examination, there was an increase in the absolute blood glucose, LVMI, and office systolic BP values, which usually was progressively and significantly more marked from the lowest to the highest quintile of baseline BMI or WC, with the exception of the LVMI change in which the trend was statistically significant for WC only. An absolute increase in home and 24-hour systolic BP was much less evident, with inconsistent differences among quintiles (please see Figure S2 ).
BMI or WC Absolute Changes and New-Onset DM, HT, and LVH
Ten-year absolute BMI or WC changes showed no significant relationships with the risk of developing DM or LVH. They did show, in contrast, a relationship with the risk of developing office, home, or ambulatory HT, the trend of an increased risk for the smallest to the largest change being in almost all of the instances statistically significant (please see Figure S3 ). 
Predictive Value of BMI and WC
The areas under the respective curve of the receiver-operating characteristic curve for the ability of baseline BMI alone and baseline WC alone to predict new-onset DM, LVH, and office, home, or ambulatory HT were both invariably well above the diagonal line (ie, the value indicating a prediction not different from chance) and in most cases did not significantly differ from each other (except for new-onset ambulatory HT and LVH, in which WC shows a better predictive capability than BMI; please see Figure S4 ). Except for new-onset office HT, the addition of baseline WC to baseline BMI significantly increased the areas under the respective curve values indicating a better predictive ability (please see Figure S5 ), whereas the addition of 10-year changes in BMI or WC never caused a further significant area under the respective curve increase (please see Table S4 ).
Discussion
Our population study provides a number of findings on the relationship between body weight and the risk of developing metabolic, BP, and cardiac abnormalities of prognostic significance and great impact for public health. The main findings can be summarized as follows. First, an increase in BMI or WC value was associated with a progressive marked increase in the incidence of new-onset DM, as well as of a condition indicating an IFG state. Second, a progressively greater BMI or WC value was accompanied also by a progressive and marked increase in the incidence of newonset HT, which was not limited to the BP values measured in the clinical environment but extended to out-of-office or daily life BP as assessed by home and ambulatory measurements. Third, the above-mentioned increase in the incidence in new-onset DM and in-office and out-of-office HT was associated with a similar progressive and marked increase in the incidence of new-onset LVH. Fourth, the increased development of the above abnormalities in glucose metabolism, BP, and cardiac structure associated with the BMI or WC abnormalities was independent of the demographic characteristics of the population, baseline glucose metabolism, BP, and echocardiographic values, as well as on the presence or absence of other cardiovascular risk factors. This allows us to conclude that, in the general population, an increase in body weight is an important independent risk factor for the appearance of conditions that may markedly enhance the chance of an individual to develop cardiovascular morbid and fatal events. Although long known for DM and HT, 9 -11,23 this has been more recently documented also for an IFG condition and LVH, either of which has been associated with a clear-cut increase in cardiovascular risk compared with individuals in which blood glucose and left ventricular mass are within the normal range. 24, 25 Several other results of our study deserve to be mentioned. First, compared with the lowest BMI or WC values, the risk of new-onset DM, HT, and LVH showed a clear-cut increase also with BMI or WC increases below values reflecting frank obesity. Thus, the risk of an increase in body weight is by no means limited to marked body weight elevations, but it materializes also for relatively modest changes above values characterizing lean subjects. Second, indeed, because in our subjects a BMI or a WC increase of just 1 kg/m 2 and 1 cm, respectively, was associated with an increase in all of the above conditions, our data provide evidence on the adverse significance of even small differences in body weight-related variables. Third, from the lowest BMI or WC values to frank obesity, the incidence of new-onset DM showed a risk elevation of Ϸ4 to 5 times, whereas the increase in the risk of new-onset HT and LVH was less marked. It, nevertheless, amounted to 2 to 3 times that seen in lean subjects, indicating that obesity plays an important role also for the appearance of high BP and cardiac damage. Fourth, our population study shows for the first time that an increase in BMI or WC represents an independent risk factor for the development not just of office but also of out-of-office high BP, that is, home and ambulatory HT. This is clinically relevant, because the association of office with ambulatory and/or home HT is accompanied by a greater increase in cardiovascular risk as compared with office HT alone. 26 Fifth, in our study, the 10-year changes in BMI or WC predicted the incidence of new-onset in-and out-of-office HT, while having no significant predictive value for new-onset LVH or DM. Furthermore, the overall predicting ability as resulting from the magnitude of area under the receiver-operating characteristic curve showed, for all of the above conditions, no improvement when BMI or WC changes were added to baseline BMI and WC values. This suggests that, in our population, original body weight characteristics were much more important than the subsequent changes, perhaps because subsequent changes reflected the original values, that is, they were progressively greater from the lowest to highest baseline BMI and WC quintile. Our data, however, refer to the white population only and, thus, cannot be safely extrapolated to other ethnic groups, considering that the relationships between body fat distribution and BP vary according to race. 27
Perspectives
Our data provide information also on the debated question of whether visceral obesity contributes to the cardiovascular risk over and above the increase associated with the body weight. The relevant points are as follows: (1) baseline BMI and WC had a similar predictive ability for new-onset DM and in-office HT, whereas new-onset ambulatory HT and LVH are better predicted by baseline WC than BMI; (2) 10-year BMI and WC changes showed a similarly limited predictive value on the above conditions, as well as a limited ability to improve the prediction offered by baseline BMI and WC values; and (3) adding baseline WC to baseline BMI was, nevertheless, capable of significantly improving the overall ability to predict out-of-office HT, DM, and LVH. Taken together, these data indicate that, in the Pressioni Arteriose Monitorate e Loro Associazioni population, the combined use of BMI and WC can improve the predictive ability of the development of markers with great cardiovascular importance, such as alterations of glucose metabolism, BP, and cardiac structure.
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